Jack Radandt was born with a rare condition called Hypoplastic Left Heart Syndrome. The condition is a congenital heart defect affecting normal blood flow through the heart.
Jack’s heart reconstruction process began at 10 days old, and his remaining two surgeries were performed before he reached the age of three. After the surgeries, he triumphed and became stronger. Jack dealt with his physical restrictions well and excelled socially & academically. He for the most part was an energetic, active boy participating in baseball, karate, zip-lining and snorkeling while on his Make-a-Wish vacation to Hawaii.
Unfortunately, at the age of 11 Jack and his family were faced with another bump in the road when they learned his heart was failing and that he needed a heart transplant. Jack was then committed to the Cardiac Intensive Care Unit (CICU) at Children’s Hospital of Wisconsin. After two months of trying different medications & therapies, the physicians caring for Jack decided to place a Heartware Ventricular Assist Device (HVAD) in him. The HVAD is a mechanical pump implanted in the heart to help blood flow in people with weakened hearts. This device was necessary to bridge the time until a donor heart was available. Jack was the first single ventricle child in the U.S. to have a HVAD placed.
Jack was able to go home with the HVAD, another milestone first. He thrived at home, gaining weight and growing taller, and was eventually able to go back to school. Three months after being discharged they received the much-awaited call that there was a heart for Jack, and it was a perfect match! He received the heart transplant and went home 11 days later. Eventually, Jack joined the basketball team, something he was unable to do before.
At the age of 16 Jack is a strong, charming, intelligent, and convincing young man who is a proud advocate for investing the time and money into new medical technology which will better the lives of those like himself. Unfortunately, not all heart disease stories have this same happy outcome, and therein lies the need for BIOLIFE4D’s innovative technology resulting in 3D bioprinting of a human heart for transplant.
BIOLIFE4D salutes Jack and his incredible mission to increase awareness for the Pediatric Congenital Heart Association and investment in new medical technology, and ultimately save countless lives. It’s a mission that’s near and dear to BIOLIFE4D, as we look to develop a new 3D bioprinting process to create fully functional human hearts suitable for transplant.
Please take a few moments and view Jack’s story: